No clinically relevant or statistically significant differences were reported between groups with respect to death ( @ -LSB- @ % -RSB- patients who received uric acid vs @ -LSB- @ % -RSB- who received placebo ) , symptomatic intracerebral haemorrhage ( nine -LSB- @ % -RSB- vs six -LSB- @ % -RSB- ) , and gouty arthritis ( one -LSB- < @ % -RSB- vs four -LSB- @ % -RSB- ) .